588 related articles for article (PubMed ID: 26085683)
21. CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis.
Oldenborg PA; Gresham HD; Lindberg FP
J Exp Med; 2001 Apr; 193(7):855-62. PubMed ID: 11283158
[TBL] [Abstract][Full Text] [Related]
22. Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody.
Narla RK; Modi H; Bauer D; Abbasian M; Leisten J; Piccotti JR; Kopytek S; Eckelman BP; Deveraux Q; Timmer J; Zhu D; Wong L; Escoubet L; Raymon HK; Hariharan K
Cancer Immunol Immunother; 2022 Feb; 71(2):473-489. PubMed ID: 34247273
[TBL] [Abstract][Full Text] [Related]
23. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα (signal regulatory protein-α) on phagocytes.
Gitik M; Liraz-Zaltsman S; Oldenborg PA; Reichert F; Rotshenker S
J Neuroinflammation; 2011 Mar; 8():24. PubMed ID: 21401967
[TBL] [Abstract][Full Text] [Related]
24. Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity.
Ring NG; Herndler-Brandstetter D; Weiskopf K; Shan L; Volkmer JP; George BM; Lietzenmayer M; McKenna KM; Naik TJ; McCarty A; Zheng Y; Ring AM; Flavell RA; Weissman IL
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):E10578-E10585. PubMed ID: 29158380
[TBL] [Abstract][Full Text] [Related]
25. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment.
Iwamoto C; Takenaka K; Urata S; Yamauchi T; Shima T; Kuriyama T; Daitoku S; Saito Y; Miyamoto T; Iwasaki H; Kitabayashi I; Itoh K; Kishimoto J; Kohda D; Matozaki T; Akashi K
Exp Hematol; 2014 Mar; 42(3):163-171.e1. PubMed ID: 24269920
[TBL] [Abstract][Full Text] [Related]
26. SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells.
Tahk S; Vick B; Hiller B; Schmitt S; Marcinek A; Perini ED; Leutbecher A; Augsberger C; Reischer A; Tast B; Humpe A; Jeremias I; Subklewe M; Fenn NC; Hopfner KP
J Hematol Oncol; 2021 Sep; 14(1):155. PubMed ID: 34579739
[TBL] [Abstract][Full Text] [Related]
27. Anti-human SIRPα antibody is a new tool for cancer immunotherapy.
Murata Y; Tanaka D; Hazama D; Yanagita T; Saito Y; Kotani T; Oldenborg PA; Matozaki T
Cancer Sci; 2018 May; 109(5):1300-1308. PubMed ID: 29473266
[TBL] [Abstract][Full Text] [Related]
28. SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells.
Piccione EC; Juarez S; Tseng S; Liu J; Stafford M; Narayanan C; Wang L; Weiskopf K; Majeti R
Clin Cancer Res; 2016 Oct; 22(20):5109-5119. PubMed ID: 27126995
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune animal models in the analysis of the CD47-SIRPα signaling pathway.
Murata Y; Saito Y; Kaneko T; Kotani T; Kaneko Y; Ohnishi H; Matozaki T
Methods; 2014 Jan; 65(2):254-9. PubMed ID: 24091004
[TBL] [Abstract][Full Text] [Related]
30. Targeting macrophage checkpoint inhibitor SIRPα for anticancer therapy.
Liu J; Xavy S; Mihardja S; Chen S; Sompalli K; Feng D; Choi T; Agoram B; Majeti R; Weissman IL; Volkmer JP
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427583
[TBL] [Abstract][Full Text] [Related]
31. Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells.
Andrejeva G; Capoccia BJ; Hiebsch RR; Donio MJ; Darwech IM; Puro RJ; Pereira DS
J Immunol; 2021 Feb; 206(4):712-721. PubMed ID: 33431660
[TBL] [Abstract][Full Text] [Related]
32. Macrophages show higher levels of engulfment after disruption of
Hayes BH; Tsai RK; Dooling LJ; Kadu S; Lee JY; Pantano D; Rodriguez PL; Subramanian S; Shin JW; Discher DE
J Cell Sci; 2020 Mar; 133(5):. PubMed ID: 31964705
[TBL] [Abstract][Full Text] [Related]
33. CD47 promotes both phosphatidylserine-independent and phosphatidylserine-dependent phagocytosis of apoptotic murine thymocytes by non-activated macrophages.
Nilsson A; Oldenborg PA
Biochem Biophys Res Commun; 2009 Sep; 387(1):58-63. PubMed ID: 19559673
[TBL] [Abstract][Full Text] [Related]
34. Innate immune 'self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation.
van den Berg TK; van der Schoot CE
Trends Immunol; 2008 May; 29(5):203-6. PubMed ID: 18394962
[TBL] [Abstract][Full Text] [Related]
35. Membrane mobility and clustering of Integrin Associated Protein (IAP, CD47)--major differences between mouse and man and implications for signaling.
Subramanian S; Tsai R; Sen S; Dahl KN; Discher DE
Blood Cells Mol Dis; 2006; 36(3):364-72. PubMed ID: 16697668
[TBL] [Abstract][Full Text] [Related]
36. Notch Signaling Modulates Macrophage Polarization and Phagocytosis Through Direct Suppression of Signal Regulatory Protein α Expression.
Lin Y; Zhao JL; Zheng QJ; Jiang X; Tian J; Liang SQ; Guo HW; Qin HY; Liang YM; Han H
Front Immunol; 2018; 9():1744. PubMed ID: 30105024
[TBL] [Abstract][Full Text] [Related]
37. Anti-SIRP
Yanagita T; Murata Y; Tanaka D; Motegi SI; Arai E; Daniwijaya EW; Hazama D; Washio K; Saito Y; Kotani T; Ohnishi H; Oldenborg PA; Garcia NV; Miyasaka M; Ishikawa O; Kanai Y; Komori T; Matozaki T
JCI Insight; 2017 Jan; 2(1):e89140. PubMed ID: 28097229
[TBL] [Abstract][Full Text] [Related]
38. The 'metabolon,' CD47, and the 'phagocytic synapse': molecular co-localization and species divergence.
Subramanian S; Tsai R; Discher DE
Transfus Clin Biol; 2006; 13(1-2):31-8. PubMed ID: 16581280
[TBL] [Abstract][Full Text] [Related]
39. High-Affinity SIRPα Variants Potentiate Antibody Therapy Efficacy.
Cancer Discov; 2013 Jul; 3(7):716. PubMed ID: 23847342
[TBL] [Abstract][Full Text] [Related]
40. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
Matlung HL; Szilagyi K; Barclay NA; van den Berg TK
Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]